Sánchez-Quesada JL - Search Results

1

Effectiveness of Bariatric Surgery in Patients with the Metabolically Healthy Obese Phenotype.

Genua I, Tuneu L, Ramos A, Stantonyonge N, Caimari F, Balagué C, Fernández-Ananin S, Sánchez-Quesada JL, Pérez A, Miñambres I. Genua I, et al. Obes Surg. 2021 Feb;31(2):517-522. doi: 10.1007/s11695-020-04967-6. Epub 2020 Sep 11. Obes Surg. 2021. PMID: 32915359

2

Electronegative low density lipoprotein subform is increased in patients with short-duration IDDM and is closely related to glycaemic control.

Sánchez-Quesada JL, Pérez A, Caixàs A, Ordónmez-Llanos J, Carreras G, Payés A, González-Sastre F, de Leiva A. Sánchez-Quesada JL, et al. Diabetologia. 1996 Dec;39(12):1469-76. doi: 10.1007/s001250050600. Diabetologia. 1996. PMID: 8960828

3

Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

Pérez A, Wägner AM, Carreras G, Giménez G, Sánchez-Quesada JL, Rigla M, Gómez-Gerique JA, Pou JM, de Leiva A. Pérez A, et al. Arch Intern Med. 2000 Oct 9;160(18):2756-62. doi: 10.1001/archinte.160.18.2756. Arch Intern Med. 2000. PMID: 11025785

4

Inaccuracy of calculated LDL-cholesterol in type 2 diabetes: consequences for patient risk classification and therapeutic decisions.

Wägner AM, Sánchez-Quesada JL, Pérez A, Rigla M, Cortés M, Blanco-Vaca F, Ordóñez-Llanos J. Wägner AM, et al. Clin Chem. 2000 Nov;46(11):1830-2. Clin Chem. 2000. PMID: 11067819 No abstract available.

5

Effect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modification.

Sánchez-Quesada JL, Pérez A, Caixàs A, Rigla M, Payés A, Benítez S, Ordóñez-Llanos J. Sánchez-Quesada JL, et al. J Clin Endocrinol Metab. 2001 Jul;86(7):3243-9. doi: 10.1210/jcem.86.7.7692. J Clin Endocrinol Metab. 2001. PMID: 11443196

6

Apo(B)-dependent dyslipidemic phenotypes in type 1 diabetic patients.

Wägner AM, Ordóñez-Llanos J, Hernández M, Sánchez-Quesada JL, Blanco-Vaca F, Rigla M, de Leiva A, Pérez A. Wägner AM, et al. Eur J Intern Med. 2001 Dec;12(6):496-502. doi: 10.1016/s0953-6205(01)00178-9. Eur J Intern Med. 2001. PMID: 11711272

7

Postprandial lipidemia is normal in non-obese type 2 diabetic patients with relatively preserved insulin secretion.

Wägner AM, Ordóñez-Llanos J, Arcelus R, Bonet R, Jorba O, Sánchez-Quesada JL, Alonso E, Julve J, Pérez A. Wägner AM, et al. Metabolism. 2003 Aug;52(8):1038-42. doi: 10.1016/s0026-0495(03)00090-8. Metabolism. 2003. PMID: 12898470 Clinical Trial.

8

Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes.

Wägner AM, Pérez A, Sánchez-Quesada JL, Ordóñez-Llanos J. Wägner AM, et al. Diabetes Care. 2005 Jul;28(7):1798-800. doi: 10.2337/diacare.28.7.1798. Diabetes Care. 2005. PMID: 15983340 No abstract available.

9

Electronegative low-density lipoprotein subfraction from type 2 diabetic subjects is proatherogenic and unrelated to glycemic control.

Benítez S, Pérez A, Sánchez-Quesada JL, Wagner AM, Rigla M, Arcelus R, Jorba O, Ordóñez-Llanos J. Benítez S, et al. Diabetes Metab Res Rev. 2007 Jan;23(1):26-34. doi: 10.1002/dmrr.643. Diabetes Metab Res Rev. 2007. PMID: 16634114

10

Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study.

Wägner AM, Sánchez-Quesada JL, Benítez S, Bancells C, Ordóñez-Llanos J, Pérez A. Wägner AM, et al. Diabetes Res Clin Pract. 2011 Jul;93(1):e25-8. doi: 10.1016/j.diabres.2011.03.009. Epub 2011 Mar 26. Diabetes Res Clin Pract. 2011. PMID: 21440948 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

132 results

Search Page

Filters